Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Potassium bitartrate is a potassium acid salt of tartaric acid. It is primarily utilized in the pharmaceutical industry as a component of **Phexxi**, an FDA-approved, non-hormonal contraceptive vaginal gel developed by **Evofem Biosciences**. In this formulation, potassium bitartrate works in conjunction with lactic acid and citric acid to maintain the natural acidic environment of the vagina (pH 3.5 to 4.5). By buffering the vaginal pH even after the introduction of alkaline semen, the gel inhibits sperm motility, thereby preventing pregnancy. Beyond its use in contraception, it is also known as cream of tartar and is widely used in the food industry and as a dietary supplement.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on potassium bitartrate.